For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
3D Bioprinting is the utilization of 3D printing and 3D printing-like techniques to combine cells, growth factors, and biomaterials to fabricate biomedical parts that maximally imitate natural tissue characteristics.
According to our (Global Info Research) latest study, the global 3D Bioprinting market size was valued at USD 9937.8 million in 2022 and is forecast to a readjusted size of USD 31640 million by 2029 with a CAGR of 18.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global 3D bioprinting market is segmented into four broad categories, namely, microextrusion, inkjet, laser-assisted, and magnetic 3D bioprinting.The global inkjet based 3D bioprinting market is anticipated to reach 1423.5 million by 2025, at a CAGR of 21.3% from 2017 to 2025.Magnetic 3D bioprinting is expected to show the fastest growth during the forecast period.
This report is a detailed and comprehensive analysis for global 3D Bioprinting market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global 3D Bioprinting market size and forecasts, in consumption value ($ Million), 2018-2029
Global 3D Bioprinting market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global 3D Bioprinting market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global 3D Bioprinting market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for 3D Bioprinting
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global 3D Bioprinting market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Organovo Holdings Inc, EnvisionTEC GmbH, Nano3D Biosciences, Inc, Cyfuse Biomedical K.K and Advanced Solutions, Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
3D Bioprinting market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Magnetic 3D Bioprinting
- Laser-assisted Bioprinting
- Inkjet 3D Bioprinting
- Microextrusion 3D Bioprinting
Market segment by Application
- Clinical Applications
- Research Applications
- Drug and Medical Research
- Regenerative Medicine
- 3D Cell Culture
Market segment by players, this report covers
- Organovo Holdings Inc
- EnvisionTEC GmbH
- Nano3D Biosciences, Inc
- Cyfuse Biomedical K.K
- Advanced Solutions, Inc
- Aspect Biosystems Ltd
- 3Dynamic Systems Ltd
- regenHU
- Cellink
- Regenovo Biotechnology Co., Ltd
- Poietis
- GeSiM
- Exone
- Stratasys
- Advanced BioMatrix
- Ricoh Company Ltd
Market segment by regions, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe 3D Bioprinting product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of 3D Bioprinting, with revenue, gross margin and global market share of 3D Bioprinting from 2018 to 2023.
Chapter 3, the 3D Bioprinting competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and 3D Bioprinting market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of 3D Bioprinting.
Chapter 13, to describe 3D Bioprinting research findings and conclusion.